Cite

HARVARD Citation

    Hill, N. et al. (2022). INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH). Pulmonary circulation. p. n/a. [Online]. 
  
Back to record